Contact: Andrea Clements
andrea.clements@jprni.com
JPR

Professor Paul Harkin, Almac

Caption: Professor Paul Harkin, President and Managing Director of Almac’s Diagnostic business unit which has devised a new test to detect likelihood of colon cancer recurring.

Credit: Almac

Usage Restrictions: None

Related news release: Northern Ireland company makes major breakthrough in cancer treatment